Home NDC 50242-078 Susvimo
Product NDC 50242-078
11-digit product format 502420078
Labeler code 50242
Product ID 50242-078_2850382e-4e4f-4005-a047-33fc758bafef
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name Ranibizumab
Dosage form INJECTION, SOLUTION
Route INTRAVITREAL
Labeler Genentech, Inc.
Application BLA761197
Marketing category BLA
Marketing start 2021-10-22
Substance RANIBIZUMAB
Active strength 100 mg/mL
Pharmacologic classes Vascular Endothelial Growth Factor Inhibitor [EPC], Vascular Endothelial Growth Factor Inhibitors [MoA]
NDC exclude flag No
Listing certified through 2026-12-31
Current FDA listing Yes Additional Listing Data#
Finished product Yes
Brand name base Susvimo
Listing expiration 2026-12-31 Active Ingredients# Ingredient, Strength table Ingredient Strength RANIBIZUMAB 100 mg/mL
Harmonized UNII identifiers# UNII identifiers page 1 of 1 · 1 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination ZL1R02VT79 Internal UNII lookup
Harmonized RxCUI identifiers# RxCUI identifiers page 1 of 1 · 2 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination 2584857 Internal RxNorm lookup 2584863 Internal RxNorm lookup
Harmonized SPL set identifiers# SPL set identifiers page 1 of 1 · 1 matching rows.
DailyMed Product Concepts# DailyMed Package Descriptions# Package NDC, Product, Description table Package NDC Product Description Form Quantity Strength SPL version 50242-078-12 Susvimo 1 in 1 CARTON INJECTION, SOLUTION 1 14 50242-078-12 Susvimo 1 mL in 1 VIAL INJECTION, SOLUTION 1 14 50242-078-55 Susvimo 1 mL in 1 VIAL INJECTION, SOLUTION 1 14 50242-078-55 Susvimo 1 in 1 CARTON INJECTION, SOLUTION 1 14
DailyMed Dashboard NDC Coverage# NDC, Dashboard title, SPL version table NDC Dashboard title SPL version Validation Dashboard ZIP 50242-078 SUSVIMO (RANIBIZUMAB) INJECTION, SOLUTION [GENENTECH, INC.] 10 Current NDC, Legacy NDC, 4 package rows 20250215_9c6d9e2a-9a77-4d11-b692-de87cfde3444.zip
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 1 matching rows.
Purple Book Biologic Products# BLA, Proprietary name, Proper name table BLA Proprietary name Proper name License type Status Latest source 761197 Susvimo ranibizumab 351(a) Rx 2026-08-01
DailyMed RxNorm Mappings# Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Units Marketing start Marketing end Sample Exclude flag Status 50242-078-12 50242007812 1 VIAL in 1 CARTON (50242-078-12) / 1 mL in 1 VIAL 1 vial 2021-10-22 0000-00-00 No No Current 50242-078-55 50242007855 1 VIAL in 1 CARTON (50242-078-55) / 1 mL in 1 VIAL 1 vial 2021-10-22 2027-09-30 No No Current